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Abstract
Mutation at position 11778 in the nd4 gene of the human mitochondrial complex I is associated with Leber’s hereditary
optic neuropathy. Type I NADH:ubiquinone oxidoreductase of Rhodobacter capsulatus displays similar properties to
complex I of the mitochondrial respiratory chain. The NUOM subunit of the bacterial enzyme is homologous to the ND4
subunit. Disruption of the nuoM gene led to a bacterial mutant exhibiting a defect in complex I activity and assembly. A
nuoM-1103 point mutant reproducing the nd4-11778 mutation has been introduced in the R. capsulatus genome. This mutant
showed a reduced ability to grow in a medium containing malate instead of lactate which indicated a clear impairment in
oxidative phosphorylation capacity. NADH supported respiration of porous bacterial cells was significantly decreased in the
nuoM-1103 mutant while no significant reduction could be observed in isolated bacterial membranes. As it has been observed
in the case of the nd4-11778 mitochondrial mutation, proton-pump activity of the bacterial enzyme was not affected by the
nuoM-1103 mutation. All these data which reproduce most of the biochemical features observed in patient mitochondria
harboring the nd4-11778 mutation show that the R. capsulatus complex I might be used as a useful model to investigate
mutations of the mitochondrial DNA which are associated with complex I deficiencies in human pathologies. ß 1998
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1. Introduction
Leber’s hereditary optic neuropathy (LHON) is a
maternally inherited disease characterized by suba-
cute to acute central vision loss due to optical nerve
atrophy [1]. The four main mutations causing LHON
occur in the mitochondrial ND genes of the respira-
tory chain complex I (NADH:ubiquinone oxidore-
ductase; EC 1.6.5.3). This enzyme catalyzes the
transfer of electrons from NADH to ubiquinone in
a process coupled to an active e¥ux of protons
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through the mitochondrial inner membrane [2,3].
The mammalian mitochondrial complex I numbers
at least 43 subunits of which seven are encoded by
the nd1^6 and nd4L genes of mtDNA [4,5]. The ND
subunits constitute the membraneous domain which
play an important role in the anchoring of the com-
plex I to the membrane and is essential for the pro-
ton-pump activity [6^8]. However, while there are
some line of evidence to suggest that rotenone bind
to ND1 [9] and that ND4 is required for complex I
assembly and activity [10], the speci¢c function of the
ND subunits is still largely unknown.
In a large number of LHON families, predisposi-
tion to the disease is tightly associated with the nd4-
11778 mtDNA mutation [11,12]. As shown in Fig. 1,
this mutation results in the substitution of an histi-
dine for an evolutionarily conserved arginine at po-
sition 340 of ND4 at the level of a predicted exposed
region. Whereas some metabolic modi¢cations indi-
cate abnormal energy metabolism in vivo [13,14], the
biochemical defects in complex I activity associated
with the mutation are still unclear [15^18]. It has also
been reported that, mitochondrial complex I from
patients carrying the nd4-11778 mutation showed a
decreased sensitivity to the speci¢c inhibitor rotenone
and it was proposed that the Arg to His substitution
could alter the ubisemiquinone binding site [19]. The
complex relationships between the various mtDNA
mutations, the impairment of oxidative phosphoryla-
tion and the associated clinical phenotypes are still
poorly understood. One has to consider that correct
assembly of the mitochondrial respiratory chain
complexes depends on the expression of both mito-
chondrial and nuclear genomes. Thus nuclear ge-
nomic background may interfere when studying spe-
ci¢c mtDNA mutations. There is also a large gap
between detailed data available at the molecular or
cellular levels and clinical observations in patients.
Furthermore, no animal models of mitochondrial
diseases caused by a de¢ciency of the respiratory
chain are available to date.
On the other hand, bacterial NADH:ubiquinone
oxidoreductases (NUO) which display similar prop-
erties to the mitochondrial complex I have been de-
scribed [20,21]. Gene clusters encoding subunits of
NUO have been characterized in Paracoccus denitri-
¢cans, Escherichia coli, Rhodobacter capsulatus and
Thermus thermophilus [22^26]. These gene clusters
contain nuoA, nuoH, nuoJ, nuoK, nuoL, nuoM and
nuoN, respectively homologous to the seven nd3, nd1,
nd6, nd4L, nd5, nd4 and nd2 mitochondrial genes.
However, while the equivalent of the major mito-
chondrial subunits, including the NDs, are present,
their subunit composition appears much simpler than
that of the mitochondrial enzyme. Furthermore, ge-
netic studies not readily applicable to the study of
the mitochondrial enzyme particularly for those sub-
units encoded by the mtDNA are easily conducted in
bacteria. For these reasons, we have developed an
enzymatic model of complex I in R. capsulatus, a
purple photosynthetic bacteria phylogenetically
linked to mitochondria. This model may allow the
biochemical characterization of mutations described
in various human mtDNA pathologies associated
with complex I de¢ciencies. Sequence comparison
between the human ND4 subunit and the R. capsu-
latus NUOM subunit has shown that the ND4
Arg340 residue is conserved in the R. capsulatus oper-
on and corresponded to the NUOM Arg368 residue
(Fig. 1). As a ¢rst step to validate this model, we
mutagenized the R. capsulatus nuo operon in order
to generate a nuoM point mutant equivalent to the
nd4-11778 mutation of the human mtDNA which
leads to the Arg340His mutation. We report here
the use of this bacterial model to investigate bio-
chemical e¡ects of this mitochondrial DNA mutation
associated with a human complex I pathology.
2. Materials and methods
2.1. Bacterial growth and preparation of membranes
The R. capsulatus reference strain used in the
present study was B10. All the derivatized strains
and mutants were grown at 30‡C in RcV medium
[27] complemented either with 40 mM Na-lactate,
30 mM Na-malate or 30 mM Na-succinate. For solid
medium cultures, anaerobic conditions were gener-
ated in Mart anaerobiosis jars using an H2/CO2 pro-
ducing chemical system (Generbox anaer, BioMe-
rieux, France). When indicated, palladium-based
catalyst was omitted. Photosynthetic growing condi-
tions were obtained by keeping the cultures under a
permanent neon white light (5000 lux). Dark and
aerobic growing conditions in liquid medium were
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produced in vigorously shaken £asks. Growth ki-
netics were followed by measuring culture turbidity
with a 2100N turbidimeter (Hach, USA). For mem-
brane preparation, cells were grown in the dark in
selected RcV media and were processed as described
in [28].
2.2. Recombinant DNA techniques
R. capsulatus nuo operon enclosing the present
nuoM gene has been sequenced [25]. Plasmids con-
structions and DNA manipulations were done fol-
lowing standard protocols [29] or as speci¢ed by
the manufacturers.
The Arg368His substitution in NUOM results from
a G1103A transition in the nuoM gene with nucleo-
tides numbering beginning with the start codon (se-
quence available at Genbank under accession num-
ber AF029365). To introduce the G1103A mutation,
we ¢rst selectively disrupted the nuoM gene and then
we speci¢cally reintroduced the point mutated nuoM
gene in the deleted strain. A suicide plasmid targeting
the R. capsulatus nuoM gene was constructed as fol-
lows: a BamHI fragment of the nuo operon enclosing
genes nuoM and nuoN was cloned in the pPHU281
suicide plasmid [30]. The SmaI fragment of the
K1XX cassette [31] was then inserted in the nuoM
gene at a unique NruI site present at position 1497.
The resulting pJL100 plasmid was ¢rst introduced
into E. coli strain S17.1 and then transferred into
R. capsulatus by parental conjugation [32]. Homolo-
gous recombination and screening for double re-
combinants were performed as described [28]. As
previously reported and to limit the potential risk
of polar e¡ects at the transcriptional level, only mu-
tants with an insertion of the K1XX cartridge in the
same transcriptional orientation as the nuo gene clus-
ter were studied here [28]. The resulting nuoM dis-
rupted mutant was called NMK1.
A mutant strain of R. capsulatus B10 with a
G1103A mutation in the nuoM gene was obtained
via directed mutagenesis using a modi¢ed pALTER
vector (Promega, USA) in which a XhoI cloning site
has been introduced. The mutated nuoM gene was
cloned into the suicide plasmid pPHU281. The mu-
tation was then transferred by parental conjugation
into NMK1 as presented in Fig. 2. The genomic
point mutant thus generated will be referred as
nuoM-1103 mutant. In order to eliminate any exper-
imentally induced modi¢cation, we conducted a con-
trol experiment in which the wild copy of the nuoM
gene was reintroduced into the NMK1 genome. The
resulting recombinant R. capsulatus cells proved to
be indistinguishable from the original B10 wild strain
both at the genetic or phenotypic levels. Alterna-
tively, a BamHI^KpnI fragment containing either
the wild-type nuoM gene or the mutated nuoM
gene was cloned into pRK415, a plasmid allowing
expression into R. capsulatus [33]. The resulting re-
combinant vector was used to trans-complement the
NMK1 mutant.
2.3. Analysis of the G1103A mutation
Alternatively to direct sequencing, the presence of
the G1103A mutation was evidenced using a PCR
mediated site-directed mutagenesis screening test
[34]. R. capsulatus B10 and nuoM-1103 mutant ge-
nomic DNA were ampli¢ed using primers 5P-
TTCGCGGCGAACCAGCAG (988^1005) and 5P-
CGCCATAGGCGGCGATCAC (1123^1105) which
generate a 136-bp DNA fragment. A mutation T to
A was introduced in the reverse primer at a position
which corresponds to the position 1106 of the nuoM
gene. This mutation created a PmlI restriction site if
the G1103A mutation was also present. Fragments
of 136 bp were obtained by PCR on wild-type B10
and nuoM-1103 mutant using the mutated primer. A
PmlI restriction digest of the 136-bp-long PCR prod-
uct generated two fragments of 117 and 19 bp in the
nuoM-1103 mutant while the fragment remained un-
cut in the B10 wild-type.
2.4. Porous cell preparation and enzymatic activities
Cultures grown aerobically in the dark in RcV
media, were harvested in late exponential phase
and pelleted at 21 000Ug for 10 min. Cells were
then resuspended in a bu¡er consisting of 1 mM
EDTA, 50 mM HEPES, pH 7.5 (0.3 ml of bu¡er
for each ml of cell culture at OD = 1). The suspension
was aliquoted in 1 ml fractions and frozen at 320‡C.
Cells were thawed at 30‡C during 3 min. They were
pelleted at 12 000Ug for 3 min and then resuspended
in 600 Wl of a bu¡er containing 50 mM HEPES,
150 mM KCl, pH 7.5. Cells were pelleted again
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and ¢nally resuspended in 600 Wl of the same bu¡er.
The resulting porous cells were then used directly in
the sample chamber of a Clark’s type electrode.
Bacterial membrane protein content was estimated
using bicinchoninic assay. Oxygen consumption in-
duced by NADH or metabolic substrates was meas-
ured with a Clark’s type electrode in a 100 mM Tri-
cine, 8 mM MgCl2, pH 7.5 bu¡er. DeaminoNADH-
oxidoreductase activity was measured at 420 nm us-
ing 1 mM K3Fe(CN)6 (O= 1 mM31 cm31 at 420 nm).
NADH oxidase activity was followed at 340 nm us-
ing 100 mM NADH (O= 6.2 mM31 cm31 at 340 nm).
Prior to measurement, 0.1 mg membrane aliquots of
wild-type or mutant strains were incubated in KPE
bu¡er (50 mM potassium phosphate, 1 mM EDTA,
pH 7.5) for 5 min at 30‡C in the presence of variable
amounts of piericidin, rolliniastatin-2 or rotenone.
Proton-pump activity of chromatophores was esti-
mated through ACMA £uorescence quenching as
described by Casadio [35] using a Fluoromax £uo-
rimeter (Jobin-Yvon SPEX, France). Piericidin was
puri¢ed in the laboratory and rolliniastatin-2 was a
generous gift of Drs Estornel and Cortes.
3. Results
3.1. Genotypic characterization of the nuoM mutants
nuoM disrupted mutant was constructed as de-
scribed in Section 2. To characterize the disruption
of the nuoM gene, genomic DNA isolated from re-
combined R. capsulatus was ampli¢ed using two prim-
ers located on either side of the NruI restriction site
used to insert the K1XX cassette. In these condi-
tions, ampli¢cation of wild-type R. capsulatus DNA
generates a fragment of 1287 bp while the disrupted
nuoM mutant strain, obtained through double re-
combination yields a 2656 bp fragment. In case of
single recombination, one would expect to obtain
both ampli¢cation products, 1287 and 2656 bp. As
shown in lane 4 of Fig. 3, the NMK1 mutant strain
obtained in this study was clearly altered at the level
of the nuoM gene as the result of a double recombi-
Fig. 1. Comparison of R. capsulatus NUOM and human ND4
subunits. (A) Sequence homologies at vicinity of the Arg340 resi-
due (boxed amino acid) of the human ND4 subunit which is
mutated in LHON. Dots indicated strictly conserved amino
acids. (B) Surface probability of the region in the human ND4
subunit overlapping Arg340 and of its counterpart in the
NUOM subunit of R. capsulatus. Pro¢les were obtained using
the MacVector software (Oxford Molecular Group, UK). More
details about complex I subunits could be found in the Mito-
Pick database at http://www-dsv.cea.fr/MitoPick/Default.html
Fig. 2. Constructions of the pJL114 suicide plasmids used to
generate the nuoM-1103 mutant through homologous recombi-
nation with NMK1. For details see Section 2.
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nation event. This was also con¢rmed by Southern
blot analysis of R. capsulatus genomic DNA using an
EcoRI-K1XX fragment and BamHI-pPHU281 DNA
as probes (not shown).
The nuoM-1103 point mutant was obtained as de-
scribed in Section 2. The presence of the G to A
transition at position 1103 of the nuoM gene was ¢rst
controlled by sequencing the pJL100 plasmid used to
construct the pJL114 recombinant vector and then at
the R. capsulatus genomic level. Since reversion of
the mutation could occur, we developed a PCR-
mediated site-directed mutagenesis test to routinely
analyze the presence of the mutation in the R. cap-
sulatus genomic DNA. As shown in Fig. 4, the pres-
ence of the nuoM-1103 mutation is easily evidenced
by the creation of a PmlI restriction site in the mu-
tated DNA. PmlI restriction patterns obtained with
the nuoM-1103 mutant indicated that the mutation
was present in the genomic DNA of the mutated
strain and that this mutated strain corresponded to
a double recombination event with the normal gene
being homologously replaced by the mutated version.
3.2. Phenotypic characterization of the disrupted
NMK1 mutant
As it has been previously observed for nuoH and
nuoL disrupted mutants [28], NMK1, the nuoM de-
leted mutant can grow on RcV lactate under dark
aerobiosis but cannot grow under anaerobic photo-
synthetic conditions in the same medium. Likewise,
membranes prepared from the NMK1 mutant are
characterized by a sharp decrease in the rate of
NADH dependent oxygen consumption as well as
in the activity of the speci¢c deaminoNADH-
Fe(CN)6 oxidoreductase. It should be noted that
the succinate dependent respiration rate is increased
in the disrupted nuoM mutant. The residual NADH-
dependent rotenone-sensitive respiration represents
less than 3% of that of wild-type membranes (Table
1). This can be correlated with the observation that
Fig. 3. PCR characterization of NMK1, the nuoM disruption
mutant. R. capsulatus genomic DNA from wild-type B10 (lane
2), simple recombinant (lane 3) and double recombinant (lane
4) isolated after recombination with the K1XX inserted nuoM
fragment were ampli¢ed using primers located on both sides of
the NruI site used to insert the K1XX cassette. The size di¡er-
ence (1369 bp) between the ampli¢ed products corresponds to
the K1XX cartridge which contains the kanamycin resistance
gene. Lane 1: size markers. Arrows indicate the position of the
forward and reverse PCR primers.
Table 1
Enzymatic activities of the membranes of the nuoM mutants
Oxygen consumption
(nmol O2 min31 mg31)
DeaminoNADH-Fe(CN)6
oxidoreductase activity
I50 for inhibitors (nM)
(nmol min31 mg31)
NADH NADH+5 WM
rotenone
Succinate Rotenone Piericidin Rolliniastastin
B10 (5) 120 þ 15 5 þ 1 104 þ 11 470 þ 45 98 þ 12 0.5 97
NMK1 (2) 11 þ 2 7 160 þ 9 79 þ 7 n.d. n.d. n.d.
nuoM-1103 (4) 124 þ 17 5 þ 2 127 þ 16 n.d. 147 þ 20 0.5 95
NADH supported respiration, deaminoNADH-Fe(CN)6 oxidoreductase activity and NADH oxidase activity were determined as de-
scribed in Section 2, values correspond to the mean value obtained from di¡erent measurements (number indicated in brackets). I5O
values for rotenone values represent the mean þ S.D. of four experiments. n.d., not determined.
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the NADH-dependent respiration of R. capsulatus
membranes is inhibitable up to 95% by rotenone.
In addition, the NMK1 mutant membranes retain
15^20% of deaminoNADH-Fe(CN)6 oxidoreductase
activity as compared to wild-type membranes. This
may indicate that part of the complex I carrying the
NADH-Fe(CN)6 oxidoreductase reaction is still as-
sembled and somehow associated with the membrane
in the NMK1 mutant. In agreement with this state-
ment, Western blot analysis of membrane extracts
from the NMK1 mutant indicated a strong signal
for the NUOC, NUOD, NUOE, NUOI and NUOJ
subunits (not shown). These data indicate that the
subunits are still synthesized and that they are inte-
grated or associated within the mutant membranes.
To further characterize NMK1, the nuoM disrupted
mutant, the proton-pump activity of isolated mem-
branes was estimated through ACMA £uorescence
quenching. As shown in Fig. 5, NADH was unable
to promote energization of the NMK1 membranes
while energization obtained after addition of succi-
nate was comparable and even higher to that of wild-
type B10 membranes. These results clearly indicate
that the e¡ect of disrupting the nuoM gene is re-
stricted to the NADH-ubiquinone oxidoreductase
and does not impair the functioning of the other
components of the respiratory chain. They also point
to the major role of the NUOM subunit for the
proton-pump activity and for the functional integrity
of the R. capsulatus complex I.
Fig. 5. Alterations of the proton pump activity of di¡erent mu-
tants. In a 4-ml £uorescence quartz cuvette were successively
added 2 ml of bu¡er (50 mM Tricine, 50 mM KCl, 0.5 mM
MgCl2, pH 7.5), then 0.5 mg of bacterial membranes, 2 Wg of
oligomycin (in ethanol) and 10 WM ACMA (in ethanol). The
system was left to equilibrate at 30‡C for 15 min. Fluorescence
was then recorded (Vex = 410 nm, Vem = 500 nm) under constant
stirring. Successive additions at indicated times were as follows:
NADH 0.2 mM, rotenone 10 WM, succinate 2.5 mM, KCN
1 mM. Total ethanol addition corresponded to 0.3% (v/v) of
the initial bu¡er volume. Upper trace corresponds to B10 wild-
type membranes, middle trace to membranes puri¢ed from the
nuoM-1103 mutant and the lower trace to membranes obtained
from NMK1, the nuoM disrupted mutant. Fluorescence inten-
sities are indicated as relative values with starting levels of £uo-
rescence being almost identical for each type of membranes.
Fig. 4. PCR-mediated characterization of the nuoM-1103 muta-
tion. The 136-bp-long fragment ampli¢ed from genomic DNA
and spanning residues 988^1123 was digested by PmlI. The
presence of the nuoM-1103 mutation in the genomic DNA gen-
erated a PmlI restriction site in the PCR fragment. PmlI diges-
tion of this fragment led to the production of two fragments,
respectively 117 and 19 bp long. Because of the gel composi-
tion, the 19-bp fragment is not visible on gels, therefore, only
ethidium bromide £uorescent signals corresponding to the uncut
136-bp fragment and to the 117-bp fragment generated after
PmlI digestion are shown in the ¢gure. Lane 1, undigested
wild-type PCR product; lane 2, undigested nuoM-1103 mutated
PCR product; lane 3, restriction digest of wild-type PCR prod-
uct; lane 4, restriction digest of the nuoM-1103 mutated PCR
product.
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3.3. Growth properties of bacterial cells carrying the
nuoM-1103 mutation
As presented in Table 2, the growth rate measured
under aerobic conditions in the dark and in a lactate
containing medium is not signi¢cantly di¡erent for
wild-type B10 and nuoM-1103 mutant bacterial cells.
This is explained by the presence of a NADH-inde-
pendent L(3) lactate dehydrogenase activity in mem-
branes of R. capsulatus [28]. As NADH-dehydrogen-
ase activity of the nuoM-1103 mutant could be
a¡ected, we measured bacterial growth rate in a ma-
late containing medium since malate is a substrate
which fuels the respiratory chain through a
NADH-linked dehydrogenase. A nearly 50% increase
in the doubling time of the nuoM-1103 mutant was
evidenced in the presence of 30 mM malate. This
indicates that the nuoM-1103 mutation is likely to
impair the e⁄ciency in the use of malate as an en-
ergetic substrate.
3.4. Respiratory capacities and biochemical phenotype
of the nuoM-1103 point mutant
As shown in Fig. 6, oxygen consumption rates
measured in nuoM-1103 mutated R. capsulatus po-
rous cells was lowered compared to that of the
wild-type B10 strain when NADH is used as a res-
piratory substrate in porous cells. This decrease in
oxygen consumption for the nuoM-1103 mutant
was also observed when malate, a substrate of the
complex I-linked dehydrogenases, was used (not
shown). However, when the same respiration meas-
urements were conducted with isolated bacterial
membranes prepared either from wild-type B10 or
from cells harboring the nuoM-1103 mutation, no
apparent variations of the respiratory activities could
be observed. To further characterize the nuoM-1103
point mutant and as the complex I is involved both
in electron-transfer and proton translocation, the
proton-pump activity of membranes isolated from
either B10 or nuoM-1103 mutant cells was estimated
Table 2
Comparison of the growth phenotype of wild-type B10 strain and nuoM mutants
Bacterial strains t1=2 (h)
Anaerobiosis Aerobiosis
RcVL RcVM RcVL
wt B10 11.2 þ 0.9 (3) 5.4 þ 0.4 (4) 1.9 þ 0.3 (5)
NMK1 s 30 n.d. 3.5 þ 0.5 (2)
nuoM-1103 10.9 þ 0.7 (2) 8.2 þ 0.5 (3) 2.0 þ 0.4 (3)
Anaerobiotic conditions were simply generated by top-¢lling gas-tight tubes with RcV-lactate medium. For aerated cultures, cells were
grown at 30‡C on RcV medium with 30 mM malate (RcVM) or 30 mM lactate (RcVL) as carbon source in 25 ml glass tubes. Tubes
were ¢lled up to 6 ml and agitated at 210 rpm with a loose cap in the dark. Kinetics were measured as described in Section 2. Num-
bers in brackets refer to independent growth kinetic measurements.
Fig. 6. Oxygen consumption of porous R. capsulatus wild-type
or nuoM-1103 cells and membranes using NADH or succinate
as respiratory substrates. Preparations of porous cells and mem-
branes and polarographic measurements were carried out as de-
scribed in Section 2. Dark bars represent wild-type B10 and
hatched bars correspond to nuoM-1103 mutant. All activities
were normalized using wild-type B10 activities as 100%. Results
represent the mean of three di¡erent measurements for porous
cells and four di¡erent measurements for isolated bacterial
membranes.
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through ACMA £uorescence quenching. As shown
in Fig. 5, NADH was able to promote an equivalent
energization of both the nuoM-1103 point mutant
and the B10 membranes either with NADH or with
succinate. Thus the proton pump activity of the com-
plex I is not impaired by the point mutation in the
nuoM gene, a very di¡erent situation from that ob-
served with NMK1, the deletion mutant. It has also
been proposed that the human nd4-11778 mutation
confers resistance of the complex I to its potent in-
hibitor rotenone [19]. Therefore we investigated in-
hibition of the respiratory activity of the complex I
induced by rotenone or by piericidin and rolliniasta-
tin, two speci¢c inhibitors of complex I. As shown in
Table 1, no variation in I50 values were found when
testing piericidin or rolliniastatin whereas the nuoM-
1103 mutation induced partial resistance to rotenone
as evidenced by the small increase in the I50 value for
rotenone.
4. Discussion
Despite the fact that the primary sequences of the
mitochondrially encoded subunits of complex I have
been identi¢ed as early as 1985 [4], very little is
known about the function of the ND subunits. In-
terestingly, the complex I of R. capsulatus consists of
14 subunits of which seven are homologous to the
seven mitochondrial ND subunits. Furthermore, it
contains a FMN cofactor and iron^sulfur clusters
which are apparently equivalent to those present in
the mitochondrial complex I [36]. Therefore it ap-
pears that the bacterial complex I stands as a good
model for the study of the structural and functional
roles of the ND subunits in complex I. Along this
line, we recently reported the individual disruption of
the nuo genes equivalent to the ND1, ND2, ND4L,
ND5 and ND6 subunits in the nuo operon of R.
capsulatus [28,37]. In all cases, the disrupted mutants
displayed a very low membrane-bound NADH-ubiq-
uinone oxidoreductase activity which indicated that
these subunits were necessary for the assembly of a
fully active enzyme. In the process of creating a point
mutant of the nuoM gene (equivalent to the nd4-
11778 mutation found in mtDNA), we ¢rst generated
NMK1, a mutant in which the nuoM gene is dis-
rupted. Membranes isolated from the NMK1 mutant
retained only 3% of the rotenone-sensitive NADH
oxidase activity found in the B10 parental strain as
analyzed by the polarography activity test. The in-
crease in the succinate driven respiration observed in
the NMK1 mutant may re£ect a compensatory adap-
tation of the complex I de¢cient mutant. This in-
crease in succinate oxidation rates has also been re-
ported for other R. capsulatus mutants disrupted in
their nuoH, nuoI, nuoJ, nuoK, nuoL, or nuoN genes
[28,37] and in the case of mitochondria harboring the
nd4-11778 mutation [16,18]. In the mitochondrial sit-
uation, the increase in succinate dehydrogenase ac-
tivity was paralleled by an increase, though lower, in
citrate synthase activity probably re£ecting a change
in the mitochondrial protein content [18]. However,
in the case of the nuo disrupted mutants of R. cap-
sulatus, at the di¡erence with the succinate dehydro-
genase activity, the lactate dehydrogenase activity
associated with the bacterial membrane was not in-
creased suggesting that the compensatory mechanism
is not a general unspeci¢c increase of enzymatic ac-
tivities [28]. On the other hand, the NMK1 mutant
membranes retained 16% of the NADH-Fe(CN)6 ox-
idoreductase activity displayed by the B10 strain. In
the mitochondrial complex I, NADH-Fe(CN)6 oxi-
doreductase activity has been associated with the ma-
trix arm of the enzyme which is formed of nuclear-
DNA encoded subunits [10,38]. Therefore, our data
may indicate that part of the enzyme involved in the
redox reactions is still assembled even though the
NUOM subunit is absent. The fact that several sub-
units (NUOC, NUOD, NUOE, NUOI) which are
supposed to be part of the extrinsic domain of the
enzyme were immunoprobed in NMK1 membranes
is in favor of these subunits being associated with
membranes even in the absence of the NUOM sub-
unit. This result is in agreement with a report show-
ing that NADH:(FeCN)6 oxidoreductase activity
was retained in mitochondrial membranes of a hu-
man cell line lacking the mitochondrial ND4 gene
product [10]. The reduced activity observed in the
membranes isolated from our NMK1 mutant is
likely to be due to a lower stability of the bacterial
complex I as compared to its mitochondrial counter-
part [39,40].
At least 12 mutations in the human mitochondrial
ND genes have been associated with Leber’s heredi-
tary optic neuropathy. Although the plethora of
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mtDNA mutations identi¢ed in families with LHON
has resulted in confusion as to the pathogenic signi¢-
cance of each mutation, the four primary mutations
at base pairs 3460, 11778, 14459 and 14484 are
present in at least 90% of families [41]. The nd4-
11778 mutation results in the replacement of a well
conserved arginine residue located at an apparently
exposed region of the ND4 subunit (Fig. 1). This
region may therefore interact with other proteins in-
volved in the NADH oxidation process [42]. It must
be noted, however, that the replacement of this argi-
nine by an histidine does not result in signi¢cant
modi¢cations of the di¡erent predicted structural
pro¢les (hydrophobicity, surface probability...) which
can be generated through the use of dedicated soft-
ware. Functional defects associated with the nd4-
11778 mutation have been investigated using mito-
chondria isolated either from tissues or cells of pa-
tients su¡ering from LHON [15,16,18] or from cy-
brid cells harboring speci¢c mtDNA mutations
[17,43]. Contradictory results have emerged from
these investigations depending on the material used
for genetic and biochemical investigation [15^18,43].
These apparent discrepancies can result from
mtDNA heteroplasmy since it has been reported
that the degree of mtDNA heteroplasmy can di¡er
in platelets and leukocytes isolated from the same
individual [44]. One has also to consider the nature
of the biological material used: intact and well
coupled mitochondria, mitochondrial homogenate,
submitochondrial particles, intact cells, detergent
fragilized cells, etc. Other parameters which may ex-
plain some discrepancies between reports concern the
nature and the concentration of the quinone sub-
strates used to measure activities [18,19,45]. As it
overcame some of these problems, the use of a bac-
terial model of complex I appeared to be of interest
to evaluate the functional impact of mutations a¡ect-
ing the ND genes. The interest of such a bacterial
system had been previously demonstrated for a mu-
tation of ATPase 6, a mitochondrial gene of the hu-
man complex V, using E. coli as a model system [46].
As has been the case for the NMK1 mutant which
reproduced most of the complex I modi¢cations de-
scribed in a human cell mutant lacking the mitochon-
drial ND4 gene product, the nuoM-1103 mutant dis-
plays biochemical and metabolic alterations found in
human cells carrying the nd4-11778 mutation. It is
commonly admitted that the nd4-11778 mutation
does not cause a drastic alteration of the energy pro-
duction in cells which harbor the mutation in their
mtDNA [17,18]. This was con¢rmed by the results
showing that the presence of the nuoM-1103 muta-
tion gave the mutant a growth advantage over
NMK1, a complex I fully de¢cient mutant. A second
piece of data in agreement with the fact that the
nuoM-1103 mutation does not impair too strongly
the energetic metabolism relies in the fact that the
presence of the nuoM-1103 does not a¡ect signi¢-
cantly the proton-pump activity of the mutant (Fig.
5). This is in agreement with Majander et al. [18]
who concluded that proton translocation was unaf-
fected in the nd4-11778 mutated cell line they used.
On the other hand, growth capacity of our mutant
on malate as carbon source in aerobiosis was signi¢-
cantly decreased (Table 2). This is in agreement with
data showing that cybrids harboring the nd4-11778
mutation exhibit a reduced ability to grow in a me-
dium containing galactose, a poor substrate for gly-
colysis [17]. NADH supported respiration of porous
R. capsulatus cells was found to be signi¢cantly de-
creased while no modi¢cation of the respiratory ca-
pacity of isolated bacterial membranes was observed.
This has to be compared to the reports showing that
a signi¢cant decrease in NADH dehydrogenase de-
pendent respiration was observed after digitonin
treatment of cells harboring the nd4-11778 mutation
[17] while no reduction in NADH dehydrogenase
activity could be detected in isolated mitochondrial
membranes [16,17,19,44]. To explain the apparent
discrepancy between results obtained with permeabi-
lized cells compared to mitochondrial particles, or
with porous cells compared to bacterial membranes,
it could be proposed that the nd4-11778 or the
nuoM-1103 mutations alter interaction between com-
plex I and NAD-linked dehydrogenases therefore al-
tering the channeling of NADH to complex I
[16,17,42]. This e¡ect is not likely to be easily evi-
denced in most enzymatic assays conducted with
membranes as an excess of NADH is used. Another
explanation would be that other respiratory com-
plexes might be altered during membrane prepara-
tion and might become limiting steps in the NADH
dependent oxygen consumption. As a consequence,
decreases in the NADH oxidase activity between
membranes prepared from mutant and wild-type
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bacteria may not be easily detectable. A last point
which has to be considered is that the NADH:qui-
none oxidoreductase activity is sensitive to the nature
and the concentration of the quinone derivatives
used in enzymatic assays [18]. Degli Esposti et al.
[19] reported an altered a⁄nity for UBQ and ubiq-
uinone-2, and a decreased sensitivity to rotenone in
mitochondria from individuals carrying the nd4-
11778 mutation. On the basis of these data, they
have proposed that the nd4-11778 mutation a¡ects
the ubisemiquinone binding site. Interestingly, we
observed a decrease of the rotenone sensitivity of
NADH dependent respiration in the nuoM-1103. It
must be noted, however, that this decrease was small-
er than in nd4-11778 mutated mitochondria.
From the data presented here, the development of
a bacterial model for the mitochondrial complex I in
R. capsulatus appears to be a valuable alternative to
investigate biochemical modi¢cations associated with
mutations of complex I genes. Furthermore, this
model may be used for biogenesis and assembly stud-
ies and it will no doubt also help to better under-
stand the role of speci¢c amino acids in the catalytic
mechanism of the bacterial enzyme through the use
of directed mutagenesis.
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